Navigation Links
Aware, Inc. Reports First Quarter 2013 Financial Results
Date:4/23/2013

the valuation allowance on deferred tax assets, which reduced our tax expense to zero, except for $2,000 of state excise taxes.

Rick Moberg , Aware's co-chief executive officer and chief financial officer, said, "Our strong operating results this quarter were driven by record revenue and profitability in our biometrics and imaging business. Biometrics revenue growth was primarily the result of a large sale to a government agency, solid international sales, and sales of licenses to OEM customers. G&A expenses benefitted from lower patent related expenses as a result of our 2012 patent sales."

About Aware
Aware is a leading software and technology supplier for the biometrics, telecommunications, and healthcare industries. Aware's biometrics software products and services are provided to solution vendors and system integrators for use by government agencies towards applications including border management, secure credentials, law enforcement, and national defense. Aware's DSL Service Assurance Group offers test and diagnostics software products that enable broadband service providers to manage their DSL networks. Aware also provides standards-based medical imaging software products to the healthcare industry.  Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts. www.aware.com

Safe Harbor Warning
Portions of this release contain forward-looking statements regarding future events and are subject to risks and uncertainties, such as estimates or projections of future revenue and earnings, and the growth of the DSL service assurance and biometrics markets. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements.

General factors include, b
'/>"/>

SOURCE Aware, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. NASDAQ Sets Ex-Dividend Date for Aware, Inc.s Special Cash Dividend of $1.80 Per Share
2. Aware, Inc. Declares Special Cash Dividend of $1.80 Per Share, or Approximately $40 Million in Total
3. Aware, Inc. Reports Third Quarter 2012 Financial Results
4. Aware, Inc. Reports Second Quarter 2012 Financial Results
5. Aware, Inc. Reports First Quarter 2012 Financial Results
6. University of Florida reports 2012 US shark attacks highest since 2000
7. Invading species can extinguish native plants despite recent reports
8. Study reports iron oxide nanoparticles effective for labeling human endothelial cells
9. Cell Transplantation reports islet cell advancement increases impact on transplantation
10. New low carbon TINA reports
11. Texas Biomed reports faster, more economical method for detecting bioterror threats
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... RedChip Global Online CEO Conference on January 29 th ... Gino Pereira , CEO of NXT-ID will present and ... the Wocket smart wallet and its full suite of ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying ... power and potential for genomic science as a means ... disease prevention and treatment.  I was honored to participate ... government-funded precision medicine program. Since the ... science of genomics—from the first sequenced genome of a ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... Early life exposure to ultraviolet A light does not cause ... scientists from The University of Texas MD Anderson Cancer Center ... Proceedings of the National Academy of Sciences . UVA ... the incidence of melanoma over the past 30 years, the ...
... coincidence, researchers working in both Turkey and Iran discovered on ... its underground nests. The females from the solitary species ... petals of pink, yellow, blue, and purple flowers. The chambers ... protect the next generation as they wait out the winter. ...
... about ovarian cancer, researchers now have something to cluck about. ... the chicken as a model to study this deadly disease ... decreases severity of ovarian cancer and increases survival in hens. ... acid, one type of omega-3 fatty acid. Several studies have ...
Cached Biology News:Researchers find melanoma not caused by early UVA light exposure 2Researchers find melanoma not caused by early UVA light exposure 3Bees that nest in petals 2Flaxseed-fed chickens shed light on ovarian cancer 2Flaxseed-fed chickens shed light on ovarian cancer 3
(Date:3/4/2015)... , Mar. 04, 2015 Research and Markets ... addition of the "Global Biologics and Biosimilars ... , The Global Biologics and ... in-depth study on the current state of the ... provides a basic overview of the industry including ...
(Date:3/4/2015)... San Bruno, CA. (PRWEB) March 04, 2015 ... Organization (CRO) headquartered in the San Francisco Bay Area, ... Clinical Trials (OCT) Israel Conference 2015 on March ... PRC Clinical seeks to build relationships with Israeli life ... Administration (FDA) clinical trials. The company’s services span all ...
(Date:3/4/2015)... CITY, Calif. , March 4, 2015 /PRNewswire/ ... ), a specialty pharmaceutical company focused on the ... treatment of acute and breakthrough pain, today announced ... 2014 financial results after market close on Monday, ... investment-community conference call at 4:30 p.m. Eastern Time ...
(Date:3/4/2015)... , March 4, 2015 Vegalab announced the ... August of last year. As part of the acquisition, ... Koo continuing his role as CEO for the ... Vegalab S.A., will work alongside Koo and oversee developments ... http://photos.prnewswire.com/prnh/20150303/179218 Koo founded Ecowin ...
Breaking Biology Technology:Global Biologics and Biosimilars Industry Report 2015-2020 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3
... debating politics are well-advised to shed more light than ... aspiration. , Light waves transmit data with much greater ... Ph.D. candidate at Lehigh University in Bethlehem, Pa. If ... circuits of an electronic chip, they can bring about ...
... The following is from Betsy McCaughey, Ph.D., the author ... the Obama Stimulus Plan."I am requesting that MSNBC and ... charges that I, Betsy McCaughey, Ph.D. was paid, directly ... the Hudson Institute, or Cantel Medical Corp. to write ...
... CAMBRIDGE, Mass., Feb. 17 Idenix Pharmaceuticals, Inc. (Nasdaq: ... and development of drugs for the treatment of human viral ... the fourth quarter and year ended December 31, 2008. At ... totaled $46.1 million. Business Highlights , ...
Cached Biology Technology:Engineers tune a nanoscale grating structure to trap and release a variety of light waves 2Engineers tune a nanoscale grating structure to trap and release a variety of light waves 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 2Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 5Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 6Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 7
Mouse monoclonal [N7519] to NR0B2 ( Abpromise for all tested applications). Antigen: E.coli expressed recombinant full length protein (Human) NR0B2 Entrez Gene ID: 8431 Swiss Protein ID: ...
DNA Repair Sampler Kit 10g each...
Zonula Adherens Sampler Kit 10 mu g each...
Caveolin Sampler Kit 10g each...
Biology Products: